Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Livedoid and necrotic skin lesions due to intra-arterial buprenorphine injections evidenced by maltese cross-shaped histologic bodies.

Schneider P, Duong TA, Ortonne N, Bagot M, Bouaziz JD.

Arch Dermatol. 2010 Feb;146(2):208-9. doi: 10.1001/archdermatol.2009.372. No abstract available.

PMID:
20157043
2.

An unusual case of livedoid and necrotic lesions in a drug addict.

Pierre-Alexandre J, François le P, Abdellah S, Karim T, Christian de G, Frédérique C.

Am J Dermatopathol. 2007 Feb;29(1):72-4.

PMID:
17284966
3.

[Necrotic livedo after injection of buprenorphine (Subutex)].

Potier A, Leclech C, Croue A, Chappard D, Verret JL.

Ann Dermatol Venereol. 2007 Feb;134(2):148-50. French.

PMID:
17375011
4.

[Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?].

Gourarier L, Lowenstein W, Gisselbrecht M, Chauveau JM, Haas C, Durand H.

Presse Med. 1996 Sep 21;25(27):1239-40. French.

PMID:
8949735
5.

Buprenorphine use by the smoking route in gaols in NSW.

Winstock AR.

Drug Alcohol Rev. 2008 Jul;27(4):449-50. doi: 10.1080/09595230802043807. No abstract available.

PMID:
18584400
6.

[Interactions with methadone and buprenorphine].

Bakke E, Bachs L.

Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2364-6. doi: 10.4045/tidsskr.09.0471. Norwegian.

7.

Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey.

Wainstein L, Bernier C, Gérardin M, Bouquié R, Espitia O, Mussini JM, Jolliet P, Victorri-Vigneau C.

Br J Dermatol. 2015;172(5):1412-4. doi: 10.1111/bjd.13503. Epub 2015 Mar 9. No abstract available.

PMID:
25353069
8.
9.

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.

Addiction. 2007 Apr;102(4):616-22. Epub 2007 Feb 6.

PMID:
17286641
10.

Embolic stroke associated with intra-carotid injection of buprenorphine.

Moisset X, Sia MA, Perie M, Ferrier A, Bourgois N.

Rev Neurol (Paris). 2015 May;171(5):450-1. doi: 10.1016/j.neurol.2015.02.008. Epub 2015 Apr 4. No abstract available.

PMID:
25851990
11.
12.

Penile and scrotal skin necrosis after injection of crushed buprenorphine tablets.

Kluger N, Girard C, Guillot B, Bessis D.

Presse Med. 2010 May;39(5):610-1. doi: 10.1016/j.lpm.2009.12.007. Epub 2010 Mar 19. No abstract available.

PMID:
20303699
13.
14.

Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.

Krook AL, Stokka D, Heger B, Nygaard E.

Eur Addict Res. 2007;13(4):216-21.

PMID:
17851243
15.

Diffuse cystic leucoencephalopathy after buprenorphine injection.

Seet RC, Rathakrishnan R, Chan BP, Lim EC.

J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):890-1. No abstract available.

16.

[Buprenorphine or methadone for detoxification of young opioid addicts?].

Ebner R, Schreiber W, Zierer C.

Psychiatr Prax. 2004 Nov;31 Suppl 1:S108-10. German.

PMID:
15570521
17.

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.

Sobel BF, Sigmon SC, Walsh SL, Johnson RE, Liebson IA, Nuwayser ES, Kerrigan JH, Bigelow GE.

Drug Alcohol Depend. 2004 Jan 7;73(1):11-22.

PMID:
14687955
18.

A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.

Kahila H, Saisto T, Kivitie-Kallio S, Haukkamaa M, Halmesmäki E.

Acta Obstet Gynecol Scand. 2007;86(2):185-90.

PMID:
17364281
19.

[Buprenorphine as opioid substitution to pregnant addicts].

Rasmussen ET, Nielsen LB.

Ugeskr Laeger. 2003 Sep 15;165(38):3607-8. Danish. No abstract available.

PMID:
14556390
20.

Pregnancy under high-dose buprenorphine.

Simmat-Durand L, Lejeune C, Gourarier L; Groupe d' Etudes Grossesse et Addictions (GEGA).

Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):119-23. doi: 10.1016/j.ejogrb.2008.10.012. Epub 2008 Dec 5.

PMID:
19058904
Items per page

Supplemental Content

Write to the Help Desk